CRISPR (Clustered Interspaced Short Palindromic Regions) technology is a revolutionary new tool that can be used to edit and detect genes, with the potential to transform the way we approach genetic engineering. This bionanotechnology was presented in a practical way just over 10 years ago, in 2012 and, due to its great impact, it was awarded the Nobel Prize in Chemistry in 2020. CRISPR is a powerful, accurate and economical way to edit genes that can be used to detect, treat and prevent genetic diseases, in addition to having potential use in other segments such as improving agricultural productivity or even creating new materials and treatments.

CRISPR technology has the potential to revolutionize the field of rapid testing and transform healthcare. It can be used to quickly diagnose diseases in any environment, even remote locations, which can significantly improve health outcomes. In addition, the molecular mechanism involved in the phenomenon is highly sensitive for the identification of respecific regions of target genes, so its use in laboratory diagnosis is promising, as the gene editing process may allow the development of more sensitive and reliable tests, as well as the production of more accessible portable diagnostic devices. This could dramatically reduce healthcare costs and improve access to and quality of healthcare. In other words, CRISPR technology has the potential to revolutionize healthcare and benefit people around the world. Investing in this technology can have a lasting impact on the world.